Our Mission

To improve the Quality of Life of patients around the world through the design, development and delivery of the highest quality innovative therapeutic solutions.

Our Company Shared Values – TEAMWORK

  • teamwork-t


    in each other

  • teamwork-e


    in everything we do

  • teamwork-a


    for actions and results

  • teamwork-m

    Market Driven

    decision making

  • teamwork-w


    to learn and grow

  • teamwork-o

    Open Minded

    to new ideas and change

  • teamwork-r


    for self and others

  • teamwork-k


    of our business and goals

Our Story

You may have heard of Repro Med Systems, Inc. That’s us! Today, we are operating as RMS Medical Products, a leading developer and manufacturer of medical devices and supplies. The company was incorporated in March, 1980 and is now publicly traded . Our stock symbol is REPR.

Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC® Hand Held Medical Suction.

We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.

RMS is excited to expand into new markets with innovative, more technical products. We look forward to productive partnerships with people and companies who share our vision and can help us effectively deliver our value promise to stakeholders in our industry.

Our Latest News & Updates

RMS Medical Products Announces Record Quarterly Sales and Net Income

RMS Medical Products Announces Record Quarterly Sales and Net Income –  Net Sales for the quarter ended June 30, 2018 increased 17.6% over the same period last year –  Net Income increased to $475,723 or 10.6% of Net Sales –  Inaugural conference call August 7th at 9:00 AM ET CHESTER, N.Y., Aug. 6, 2018 /PRNewswire/ … Continued

Meet Our Executive Team

  • Daniel S. Goldberger

    Chairman of the Board of Directors, Interim President and CEO

    Mr. Goldberger was appointed as Chairman of the Board of Directors and interim President and Chief Executive Officer on July 25, 2018, replacing  Mr. Andrew Sealfon.  Mr. Goldberger has over 35 years of experience within the biotech, medical technology, and high tech industries.  His areas of expertise include mergers and acquisitions, capital formation, intellectual property, product development, supply chain, business analytics, and turnarounds.   Since January 2018, Mr. Goldberger is the Chief Executive Officer of Synergy Disc Replacement Inc., a private company commercializing a proprietary total disc implant for cervical spine therapy.  Prior to this, Mr. Goldberger served as Chief Executive Officer of Milestone Medical, Inc. until October 2017.  Prior to this he served as the Chief Executive Officer of Xtant Medical Holdings, Inc. from August 2013 to January 2017. He served as the Chief Executive Officer of Sound Surgical Technologies LLC from April 2007 to February 2013. Mr. Goldberger served on the boards of Xtant Medical Holdings, Inc., Sound Surgical, Xcorporeal and Glucon. He currently serves as an advisor to investment funds Meridian Capital and Wellfleet Capital. Mr. Goldberger earned his B.S. in Mechanical Engineering from M.I.T, his M.S. in Mechanical Engineering from Stanford University and attended the Stanford Directors College.

  • Dr. Fred Ma


    Dr. Fred Ma brings over 30 years of broad experience based on his neurosurgical practice, with significant emphasis in pharmaceuticals and medical device industries. Dr. Ma has a successful track record in all phases of product research and development culminating in final approvals, clearances, and commercialization. He is prominent within regulatory agencies and a multitude of professional organizations. Dr. Ma has directly designed and supervised numerous product developments, 600 clinical trials and many successful regulatory approvals and clearances worldwide.  He ushers in significant business growth with noteworthy achievement in bringing new products to market with agile skill. Dr. Ma earned his M.D. degree from Capital University of Medical Sciences, Beijing, D.M.Sc. (Doctorate of Medical Sciences (equivalent to combined M.D. and Ph.D. degrees) from Tokyo University, Japan, and a Ph.D. from Rutgers University.

  • Karen Fisher


    Karen Fisher has more than 25 years of financial experience in a variety of industries, most recently serving as the Assistant Controller for a global consumer products company. She has also held roles such as Chief Accounting Officer and Treasurer, and Controller. Ms. Fisher held multiple financial management roles covering financial analysis and reporting, budgeting, forecasting, acquisitions, and cash management.  She is thoroughly knowledgeable in compliance with SEC regulation, GAAP, 10Q’s, 10K’s and Sarbanes-Oxley.  Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in Accounting.

  • Manuel Marques

    VP Operations

    Manny Marques has an engineering background in FDA Class II & III medical devices. He has a proven history of effectively transferring new products from R&D into manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques.  Mr. Marques holds two U.S. patents for cardiovascular medical devices.  Manny obtained a BS in Mechanical Engineering Technology and also an MS in Engineering Management from the New Jersey Institute of Technology.

Investor Relations